동국생명과학 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 김영선, was filed 02 Jul 2026.
동국생명과학: what insiders have been doing
동국생명과학, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). Over the twelve months to 2 November 2026, 3 filings were filed, from 2 insiders.
The flow runs one way only: 2 insiders bought (3 purchases totalling €19k) and nobody sold on the market. No amount is published for 2 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 1 senior executive. At €19k, the purchase published on 9 April 2026 by 김영선 is the largest of the period (0.041% of market cap).
The last insider purchase was made public on 2 July 2026, 130 days ago.
Compared with its exchange (2,655 companies, median 7 filings), a count of 3 filings is below the norm. Since 2025, the database holds 4 purchases and no sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -36.5%Entry ₩3,300 · Close 30 Oct 2026 ₩2,095
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 10,000 sharesShareKRXDART:20260702000438Canonical exit: 30 Sept 2026 (T+90)
- 10,000 shares@ ₩3,325.000.041% mcap100.0% of flowShareKRXDART:20260409001626Canonical exit: 7 Jul 2026 (T+90)
- 538,644 sharesKRXDART:20251210000503Canonical exit: 5 Mar 2026 (T+90)
- 2,150 sharesShareKRXDART:20250408003342Canonical exit: 7 Jul 2025 (T+90)
4 of 4 declarations
About 동국생명과학
Dongguk Life Science is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and manufacturing of biopharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
